Pitfalls in genotypic antimicrobial susceptibility testing caused by low expression of blaKPC in Escherichia coli

There is a growing interest in the rapid genotypic identification of antimicrobial resistance (AMR). In routine diagnostics, we detected multiple KPC-positive Escherichia coli (KPC-Ec) with discordant phenotypic meropenem susceptibility from a single patient’s blood cultures, which prompted a more t...

Full description

Saved in:
Bibliographic Details
Main Authors: Kocer, Kaan (Author) , Klein, Sabrina (Author) , Hildebrand, Dagmar (Author) , Krall, Lars Johannes (Author) , Heeg, Klaus (Author) , Boutin, Sébastien (Author) , Nurjadi, Dennis (Author)
Format: Article (Journal)
Language:English
Published: 29 July 2021
In: The journal of antimicrobial chemotherapy
Year: 2021, Volume: 76, Issue: 11, Pages: 2795-2801
ISSN:1460-2091
DOI:10.1093/jac/dkab267
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/jac/dkab267
Get full text
Author Notes:Kaan Kocer, Sabrina Klein, Dagmar Hildebrand, Johannes Krall, Klaus Heeg, Sébastien Boutin, Dennis Nurjadi
Description
Summary:There is a growing interest in the rapid genotypic identification of antimicrobial resistance (AMR). In routine diagnostics, we detected multiple KPC-positive Escherichia coli (KPC-Ec) with discordant phenotypic meropenem susceptibility from a single patient’s blood cultures, which prompted a more thorough investigation.We investigated the potential clinical relevance of, and the mechanism behind, discordant phenotypic and genotypic meropenem susceptibility in KPC-Ec.WGS was used to perform a comparative analysis of the isolates’ genetic characteristics and their blaKPC-2 locus. Expression of blaKPC-2 was determined by quantitative PCR and the potency of meropenem hydrolysis was determined using a semi-quantitative carbapenem inactivation method. An in vivo infection assay using Galleria mellonella was performed to assess the potential clinical relevance of KPC expression in E. coli.Despite the presence of blaKPC-2, three of five isolates were susceptible to meropenem (MICVITEK2≤0.25 mg/L), while two isolates were resistant (MICVITEK2≥16 mg/L). The isolates with high MICs had significantly higher blaKPC-2 expression, which corresponds to phenotypic meropenem inactivation. The genetic environment of blaKPC-2, which may impact KPC production, was identical in all isolates. In vivo infection assay with G. mellonella suggested that meropenem was effective in reducing mortality following infection with low-expressing KPC-Ec.Our findings clearly highlight a limitation of genotypic AMR prediction for blaKPC. For the time being, genotypic AMR prediction requires additional analysis for accurate antibiotic therapy decision-making.
Item Description:Gesehen am 28.01.2022
Physical Description:Online Resource
ISSN:1460-2091
DOI:10.1093/jac/dkab267